Born and raised in the pharma industry

NNE is an international company, specialised in pharma engineering. We help pharmaceutical companies bring products to market by providing flexible, compliant and future-proof solutions.

We have close to 2,000 professionals dedicated to delivering global knowledge and best practices to customers all over the world. Through focused pharma engineering, we enable our customers to deliver on demand.

Our values

Vision

Vision

To be the leading pharma engineering company by being perceived as trusted advisors by our customers, being the preferred employer within pharma engineering, and by delivering competitive and sustainable business results.

Mission

Mission

To help pharmaceutical companies bring products to market by providing flexible, compliant and future-proof solutions based on reliable project execution.

Our history

1930’s

1930’s

Danish Novo and Nordisk Gentofte (later Novo Nordisk) employed the first engineers.

1991

1991

After functioning as in-house consultants at Novo Nordisk for years, NNE (Novo Nordisk Engineering A/S) demerged as an independent company.
At this time the employee count was 130.

1998

1998

Novolet complet, Hilleroed, Denmark. Handover of a highly automated Novo Nordisk plant for fill, finish and assembly of insulin pens based on a new manufacturing concept.

2005

2005

NNE wins facility-of-the-year award for Novo Nordisk’s biotechnological plant for production of hemophilia medicine (FVII), NovoSeven®, situated in Hillerød, Denmark.
A fast-track engineering project completed in only 18 months.

2007

2007

Acquisition of Pharmaplan, a company similar to NNE in DNA. NNE Pharmaplan was founded.
With the acquisition, we obtained global coverage of the market.

2017

2017

To make our name simpler, easy to remember and conversational, we changed our company name to NNE.
But our focus on pharma engineering remains unchanged. We now have around 2,000 employees at more than 15 office locations.